Related references
Note: Only part of the references are listed.Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition
E. Hendrick et al.
ONCOGENE (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Developing New Treatments for Heart Failure Focus on the Heart
Mihai Gheorghiade et al.
CIRCULATION-HEART FAILURE (2016)
Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle
Douglas D. Lemon et al.
FEBS LETTERS (2015)
The Nuclear Factor Erythroid 2-Related Factor 2 Activator Oltipraz Attenuates Chronic Hypoxia-Induced Cardiopulmonary Alterations in Mice
Shunsuke Eba et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Increased Oxidative Stress in the Nucleus Caused by Nox4 Mediates Oxidation of HDAC4 and Cardiac Hypertrophy
Shouji Matsushima et al.
CIRCULATION RESEARCH (2013)
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
Yang Bai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy
Bradley S. Ferguson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2
Yifan Xing et al.
PLOS ONE (2012)
Plaque Assay for Murine Norovirus
Mariam B. Gonzalez-Hernandez et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension
Douglas D. Lemon et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
ConsensusPathDB: toward a more complete picture of cell biology
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2011)
A Small-Molecule Inducer of the Antioxidant Response Element
Wooyoung Hur et al.
CHEMISTRY & BIOLOGY (2010)
Modulation of Angiotensin II-Mediated Cardiac Remodeling by the MEF2A Target Gene Xirp2
Sarah A. McCalmon et al.
CIRCULATION RESEARCH (2010)
Chemical phylogenetics of histone deacetylases
James E. Bradner et al.
NATURE CHEMICAL BIOLOGY (2010)
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Jinqing Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy
Shin-ichi Oka et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
ConsensusPathDB-a database for integrating human functional interaction networks
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2009)
Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes
Tomonaga Ichikawa et al.
PLOS ONE (2009)
A redox-dependent pathway for regulating class IIHDACs and cardiac hypertrophy
Tetsuro Ago et al.
CELL (2008)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Unraveling the hidden catalytic activity of vertebrate class Ila histone deacetylases
A. Lahm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Derepression of pathological cardiac genes by members of the CaM kinase superfamily
Timothy A. McKinsey
CARDIOVASCULAR RESEARCH (2007)
Disruption of the Keap1-containing ubiquitination complex as an antioxidant therapy
Jonathan T. Kern et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related α-actinin-interacting protein
Hsuan-Ting Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10
Shurong Chang et al.
CELL (2006)
Regulation of cardiac stress signaling by protein kinase D1
Brooke C. Harrison et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development
SR Chang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Prognostic significance of left ventricular mass change during treatment of hypertension
RB Devereux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Subtype selective substrates for histone deacetylases
B Heltweg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop
H Kook et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases
JR Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
